Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Endo Pharms drug MEGACE ES appeared first on DrugP…
New patent expiration for Endo Pharms drug MEGACE ES Read Post »
Annual Drug Patent Expirations for TRICOR Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in three NDAs. It is available from five suppliers. There are…
The post New patent expiration for Abbvie drug TRICOR appeared first on DrugPate…
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first …
BEVYXXA (betrixaban) Portola pharms inc Patent: 9,629,831 Expiration: Sep 15, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Pa…
Drug Patent Expirations for the Week of September 13, 2020 Read Post »
Annual Drug Patent Expirations for BEVYXXA Bevyxxa is a drug marketed by Portola Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Portola Pharms drug BEVYXXA appeared first on D…
New patent expiration for Portola Pharms drug BEVYXXA Read Post »
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fifteen…
The post Patent delisted for Boehringer Ingelheim drug TRIJARDY XR a…
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post Patent delisted for Merck Sharp drug PREVYMIS appeared first on DrugP…
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post Patent delisted for Veloxis Pharms drug ENVARSUS XR appeared first on…
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post Patent delisted for Veloxis Pharms drug ENVARSUS XR appeared first on…
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are thirty-one…
The post Patent delisted for Otsuka drug ABILIFY MYCITE KIT appea…
Patent delisted for Otsuka drug ABILIFY MYCITE KIT Read Post »